4D Molecular Therapeutics

Last updated: April 15, 2024

David Kirn - CEO, Co-founder, Chairman
David Kirn - CEO, Co-founder, Chairman
Country: USA | Funding: A$990K (+)

Website: https://www.4dmoleculartherapeutics.com/

4D Molecular Therapeutics is unlocking the full potential of the gene therapy field. Our customized AAV vectors can deliver genes to any cell in the body to eradicate disease.